Last month, James Riddle, Advarra Vice President of Institutional Services presented the webinar Accelerating the Recovery – IRB Review of Virtual Trial Technology. In a follow-up blog, he takes a deeper dive into the topic, exploring key issues IRB face when reviewing research involving mHealth and virtual trial applications. He discusses two approval criteria bearing particular importance in this review:
- Will the technology produce reliable data?
- Are the confidentiality risks known and adequately disclosed?
James also describes ways IRBs can prepare for increased use of virtual trial technologies.
To find out more about IRB review of virtual trial technologies, read the full article on Advarra’s website.